Skip to content
10-Q

Quarterly Report

Telesis Bio Inc.

0000950170-24-057423

← back to feed
Filed
May 10, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 8, 2024 1.68M sh
Shares Diluted Q1 2024 · Mar 31, 2024 1.67M sh
Shares Diluted restated Q1 2024 · Mar 31, 2023 1.65M sh
Capex Q1 2024 · Mar 31, 2024 $502K
Capex Q1 2024 · Mar 31, 2023 $470K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$3.24M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$11.17M
Long Term Debt Q1 2024 · Mar 31, 2024 $5.22M
Long Term Debt Q1 2024 · Dec 31, 2023 $5.27M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $10.62M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $1.57M
Stockholders Equity Q1 2024 · Mar 31, 2024 −$8.24M
Stockholders Equity Q1 2024 · Dec 31, 2023 $238K
Stockholders Equity Q1 2024 · Mar 31, 2023 $36.62M
Stockholders Equity Q1 2024 · Dec 31, 2022 $46.57M
Current Liabilities Q1 2024 · Mar 31, 2024 $6.41M
Current Liabilities Q1 2024 · Dec 31, 2023 $8.18M
Total Liabilities Q1 2024 · Mar 31, 2024 $41.68M
Total Liabilities Q1 2024 · Dec 31, 2023 $40.87M
Current Assets Q1 2024 · Mar 31, 2024 $23.4M
Current Assets Q1 2024 · Dec 31, 2023 $30.35M
Total Assets Q1 2024 · Mar 31, 2024 $63.33M
Total Assets Q1 2024 · Dec 31, 2023 $70.41M
Eps Diluted Q1 2024 · Mar 31, 2024 −$5.52
Eps Diluted restated Q1 2024 · Mar 31, 2023 −$6.75
Eps Basic Q1 2024 · Mar 31, 2024 −$5.52
Eps Basic restated Q1 2024 · Mar 31, 2023 −$6.75
Sga Expense Q1 2024 · Mar 31, 2024 $5.37M
Sga Expense Q1 2024 · Mar 31, 2023 $5.55M
Rd Expense Q1 2024 · Mar 31, 2024 $2.93M
Rd Expense Q1 2024 · Mar 31, 2023 $5.12M
Net Income Q1 2024 · Mar 31, 2024 −$8.64M
Net Income Q1 2024 · Mar 31, 2023 −$11.12M
Operating Income Q1 2024 · Mar 31, 2024 −$8.52M
Operating Income Q1 2024 · Mar 31, 2023 −$10.97M
Gross Profit Q1 2024 · Mar 31, 2024 $1.45M
Gross Profit Q1 2024 · Mar 31, 2023 $3.51M
Cost Of Revenue Q1 2024 · Mar 31, 2024 $1.99M
Cost Of Revenue Q1 2024 · Mar 31, 2023 $2.81M
Revenue Q1 2024 · Mar 31, 2024 $3.44M
Revenue Q1 2024 · Mar 31, 2023 $6.32M